Publications by authors named "Linong Ji"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

938,463

Total Likes

23,415

Extended Reach

2,190,898

Social Features

310
N
New-Onset Diabetes in Covid-19.
Francesco Rubino, Stephanie A Amiel, Paul Zimmet, George Alberti, Stefan Bornstein, Robert H Eckel, Geltrude Mingrone, Bernhard Boehm, Mark E Cooper, Zhonglin Chai

August 2020

Videos about Article: user user user 1

4 16 294 16 336 6

View All Article and Social Media Activity
A
Associations between metformin use and vitamin B levels, anemia, and neuropathy in patients with diabetes: a meta-analysis.
Wenjia Yang, Xiaoling Cai, Haiya Wu, Linong Ji

J Diabetes· September 2019

Videos about Article: user

1 12 11 4

View All Article and Social Media Activity
R
Reevaluating the causal link between liver fat and hyperglycaemia.
Zhaoqian Xu, Qi Huang, Xinlei Zhang, Song Wang, Yingying Luo, Linong Ji

Diabetes Obes Metab· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Addressing unmet needs for chronic kidney disease treatment in type 1 diabetes: A review.
Katherine R Tuttle, Linong Ji, Chantal Mathieu, Jonathan Rosen

Diabetes Obes Metab· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Control of the cardiovascular risk factors in patients with type 2 diabetes mellitus in China in 2023-2024.
Wenjia Yang, Xiaoling Cai, Qiuhe Ji, NanWei Tong, Ming Liu, Zhongjing Wang, Mingjing Bao, Jingya Yan, Linong Ji

Diabetes Obes Metab· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heterogeneous Covariates-Aware Pseudo Supervised Meta-Learning for Few-Shot Diabetes Classification.
Lei Wang, Wei Liu, Deheng Cai, Linong Ji, Dawei Shi

IEEE Trans Comput Biol Bioinform· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GRADE notes 6: Three strategies to determine the clinically important thresholds for outcomes in evidence-based guideline development.
Xiaomei Yao, Jun Xia, Marisa Deodat, Peiyao Wang, Yaping Chang, Linong Ji

J Clin Epidemiol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Morning spot urinary cortisol-to-creatinine ratio: a novel screening tool for assessing excess cortisol secretion.
Yingning Liu, Ping Zhang, Simin Zhang, Ying Gao, Yiqing Mu, Linong Ji

Front Endocrinol (Lausanne)· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-diabetic medications and cancer: links beyond glycemic and body weight control.
Meng Cao, Chu Lin, Xiaoling Cai, Fang Lv, Wenjia Yang, Linong Ji

Precis Clin Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intensive blood pressure reduction but an increased risk of peripheral arterial disease: a systematic review and meta-analysis of randomized controlled trials.
Ruoyang Jiao, Chu Lin, Zonglin Li, Xingyun Zhu, Xiaoling Cai, Wenjia Yang, Linong Ji

Ann Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utility of continuous glucose monitoring in people with type 2 diabetes on insulin-based regimens in clinical practice: A case series and expert opinion.
Soo Lim, Rimei Nishimura, Jothydev Kesavadev, Alice Pik Shan Kong, Margaret J McGill, Linong Ji

Diabetes Res Clin Pract· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular Outcomes with Tirzepatide versus Dulaglutide in Type 2 Diabetes.
Stephen J Nicholls, Imre Pavo, Deepak L Bhatt, John B Buse, Stefano Del Prato, Linong Ji

N Engl J Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of oral semaglutide in Chinese participants with type 2 diabetes: Subgroup analyses by baseline characteristics in the PIONEER 11 and 12 randomised controlled trials.
Linong Ji, Guoyue Yuan, Jun Liu, Bingjie Zhang, Wenyan Liu

Diabetes Obes Metab· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety benefits of HR17031, a fixed-ratio combination of INS068 and noiiglutide, versus its components alone in Chinese patients with type 2 diabetes uncontrolled on oral antidiabetic drug(s): A phase 2, multicentre, open-label, randomised, parallel three-arm, treat-to-target trial.
Linong Ji, Debing Huang, Xiang Lin, Xue Dong, Lu Li

Diabetes Obes Metab· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term efficacy and safety of tirzepatide in participants with type 2 diabetes with inadequate glycaemic control on metformin and/or sulfonylurea: Post-hoc analysis of SURPASS-4.
Haixia Guan, Hongwei Jiang, Huijuan Yuan, Jie Sun, Jiawei Xu, Linong Ji

Diabetes Obes Metab· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Global challenges in diabetes research and care: which way forward? An appraisal from the EASD Global Council.
Francesco Giorgino, Fawaz Alzaid, Anca Pantea Stoian, Juliana C N Chan, Linong Ji

Diabetologia· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regional, age-specific and sex-specific trends in the prevalence of overweight or obesity in type 1 diabetes from 1980 to 2020: a meta-analysis of 78 observational studies with 650,265 participants.
Yuchen Guo, Chu Lin, Xiaoling Cai, Han Wu, Jingya Yan, Ruoyang Jiao, Wenjia Yang, Linong Ji

Diabetes Res Clin Pract· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IGF-1R Inhibitor IBI311 for the Treatment of Active Thyroid Eye Disease in Chinese Patients: The RESTORE-1 Randomized Clinical Trial.
Haiyang Zhang, Jing Sun, Yinwei Li, Limin Zhu, Zhongyan Shan, Jie Shen, Hongwei Jiang, Linong Ji, Yanjie Tian, Jianbo Zhou, Jie Qiao, Junjie Deng, Shujie Lu

JAMA Ophthalmol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Weight Loss, Obesity Medication, and Risk of Obesity-Associated Cancer: A Meta-Analysis of Randomized Controlled Trials.
Chengwen Li, Chu Lin, Xiaoling Cai, Fang Lv, Wenjia Yang, Linong Ji

Obesity (Silver Spring)· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mazdutide versus Semaglutide for the treatment of type 2 diabetes and obesity: Rationale, design and baseline data of DREAMS-3 phase 3 trial.
Yingying Luo, Hongwei Jiang, Bimin Shi, Hanqing Cai, Haifang Wang, Linong Ji

Contemp Clin Trials· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Effectiveness of Insulin Glargine 300 U/ml in People with Type 2 Diabetes Previously Treated with Tirzepatide: The DELIVER-T Study.
Robert Ritzel, Melanie J Davies, Lichen Hao, Linong Ji, Lintu Mk

Diabetes Ther· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of insulin degludec/insulin aspart biosimilar B01711 vs originator insulin degludec/insulin aspart in Chinese patients with type 2 diabetes inadequately controlled on basal or premixed insulin: A multicenter, randomized, open-label, phase 3 study.
Leili Gao, Zhifeng Cheng, Guoqing Ma, Xiaojun Cai, Xiaoyun Wang, Jianlin Geng, Jingfang Sun, Linong Ji

J Diabetes Investig· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The predictive value of serum MHR combined with classical metabolic syndrome components in the first trimester for gestational metabolic syndrome: a prospective cohort study in China.
Sixu Xin, Linong Ji, Xiaomei Zhang, Yuehan Ma, Xin Zhao, Jianbin Sun

Front Med (Lausanne)· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk factors for progression to albuminuria in individuals with newly diagnosed type 2 diabetes: a 5-year cohort study.
Lingli Zhou, Junxia Yu, Xiaoling Cai, Yu Zhu, Meng Li, Linong Ji

BMC Endocr Disord· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Once-Weekly Mazdutide in Obesity or Overweight. Reply.
Linong Ji, Lei Qian

N Engl J Med· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterizing echocardiographic abnormalities and their associated factors in patients with type 1 diabetes: a cross-sectional study.
Wenfeng Yang, Chu Lin, Xiaoling Cai, Zonglin Li, Fang Lv, Wenjia Yang, Linong Ji

Cardiovasc Diabetol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PCSK9 Inhibitor and Potential Decreased Risk of Neoplasms, Especially in Females: A Meta-Analysis.
Tingyang Wei, Zonglin Li, Chu Lin, Yuteng Yang, Changjie Tie, Wenjia Yang, Linong Ji

Pharmaceuticals (Basel)· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis